eHealthMe - Personalized health information & community eHealthMe - Personalized health information & community

Personalized health information & community


All drugs: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
All conditions: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Check symptoms   -   Check drugs   -   Compare drugs   -   Join a support group   -   More tools

From FDA reports: drug interactions between Sprycel, Allopurinol, Hydrea, Gleevec, Aranesp for a Female patient aged 57

This is a personalized study for a 57 year old female patient. The study is created by eHealthMe based on reports of 8 people who take the same drugs and have drug interactionsfrom FDA.

On Apr, 1, 2015: 8 people who reported to have interactions when taking Sprycel, Allopurinol, Hydrea, Gleevec, Aranesp are studied

Trend of Sprycel, Allopurinol, Hydrea, Gleevec, Aranesp's drug interactions, side effects, and effectiveness reports (3740317)

Information of the patient in this study:

Age: 57

Gender: female

Conditions: Chronic Myeloid Leukaemia, Anaemia

Drugs taking:
- Sprycel
- Allopurinol
- Hydrea
- Gleevec: used for 6 - 12 months
- Aranesp: used for 1 - 6 months

Drug interactions have: Thrombocytopenia, Neutropenia, Basal Cell Carcinoma, Anaemia

eHealthMe real world results:

Comparison with this patient's adverse outcomes among females aged 57 (±5):

InteractionNumber of reports
Thrombocytopenia1 (100.00%)
Neutropenia1 (100.00%)
Basal Cell Carcinoma1 (100.00%)
Anaemia1 (100.00%)

Most common interactions experienced by females aged 57 (±5) in the use of Sprycel, Allopurinol, Hydrea, Gleevec, Aranesp:

InteractionNumber of reports
Thrombocytopenia1
Neutropenia1
Basal Cell Carcinoma1
Anaemia1

Most common interactions experienced by females aged 57 (±5) in long term use of Sprycel, Allopurinol, Hydrea, Gleevec, Aranesp:

None.

For people in general (regardless of gender or age):

Comparison with this patient's adverse outcomes:

InteractionNumber of reports
Thrombocytopenia2 (25.00%)
Neutropenia2 (25.00%)
Basal Cell Carcinoma2 (25.00%)
Anaemia2 (25.00%)

Most common interactions experienced by people in the use of Sprycel, Allopurinol, Hydrea, Gleevec, Aranesp:

InteractionNumber of reports
Renal Failure Acute4
Vomiting4
Subcutaneous Abscess4
Death4
Bone Marrow Failure4
Gastrointestinal Haemorrhage4
Respiratory Tract Infection4
Anaemia2
Basal Cell Carcinoma2
Neutropenia2

Most common interactions experienced by people in long term use of Sprycel, Allopurinol, Hydrea, Gleevec, Aranesp:

InteractionNumber of reports
Vomiting2
Renal Failure Acute2
Gastrointestinal Haemorrhage2

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

You can also:

 

 

 

NOTE: The study is based on active ingredients. Other drugs that have the same active ingredients are also considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

   

About - Terms of service - Privacy policy - Press - Testimonials - Contact us - eHealth.me

 
© 2015 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.